Correlation Between Equillium and Marinus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Equillium and Marinus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Equillium and Marinus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Equillium and Marinus Pharmaceuticals, you can compare the effects of market volatilities on Equillium and Marinus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Equillium with a short position of Marinus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Equillium and Marinus Pharmaceuticals.
Diversification Opportunities for Equillium and Marinus Pharmaceuticals
0.25 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Equillium and Marinus is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Equillium and Marinus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Marinus Pharmaceuticals and Equillium is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Equillium are associated (or correlated) with Marinus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Marinus Pharmaceuticals has no effect on the direction of Equillium i.e., Equillium and Marinus Pharmaceuticals go up and down completely randomly.
Pair Corralation between Equillium and Marinus Pharmaceuticals
Allowing for the 90-day total investment horizon Equillium is expected to generate 0.9 times more return on investment than Marinus Pharmaceuticals. However, Equillium is 1.12 times less risky than Marinus Pharmaceuticals. It trades about 0.03 of its potential returns per unit of risk. Marinus Pharmaceuticals is currently generating about -0.04 per unit of risk. If you would invest 84.00 in Equillium on September 12, 2024 and sell it today you would lose (14.00) from holding Equillium or give up 16.67% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Equillium vs. Marinus Pharmaceuticals
Performance |
| Timeline |
| Equillium |
| Marinus Pharmaceuticals |
Equillium and Marinus Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Equillium and Marinus Pharmaceuticals
The main advantage of trading using opposite Equillium and Marinus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Equillium position performs unexpectedly, Marinus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Marinus Pharmaceuticals will offset losses from the drop in Marinus Pharmaceuticals' long position.| Equillium vs. Lyra Therapeutics | Equillium vs. Hookipa Pharma | Equillium vs. Jasper Therapeutics | Equillium vs. Cingulate Warrants |
| Marinus Pharmaceuticals vs. Equillium | Marinus Pharmaceuticals vs. DiaMedica Therapeutics | Marinus Pharmaceuticals vs. Valneva SE ADR | Marinus Pharmaceuticals vs. Vivani Medical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |